Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  UCB SA    UNC   BE0003739530

UCB SA (UNC)

0
Real-time Quote. Real-time Tradegate - 07/23 04:00:39 pm
66.925 EUR   +4.68%
07/04 UCB : Acquisition of own shares
06/25 UCB : Patent Issued for Pharmaceutical Composition Comprising Rotigotine Sa..
06/25 UCB : Acquisition of own shares
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse AG
07/17/2014 07/18/2014 07/21/2014 07/22/2014 07/23/2014 Date
64.9(c) 63.84(c) 63.66(c) 63.934(c) 65.498(c) Last
11 0 4 0 0 Volume
+1.86% -1.63% -0.28% +0.43% +2.45% Change
More quotes
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders. The company focuses on the development of innovative medicines. It sells bio-pharmaceutical products for... 
Sector
Pharmaceuticals
Calendar
07/30 | 01:00amEarnings Release
Surperformance© rating of UCB SA
Trading Rating : Investor Rating :
More about the company
Chart UCB SA
Duration : Period :
UCB SA Technical Analysis Chart | UNC | BE0003739530 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 521 M
EBIT 2014 504 M
Net income 2014 269 M
Debt 2014 1 634 M
Yield 2014 1,67%
Sales 2015 3 791 M
EBIT 2015 637 M
Net income 2015 380 M
Debt 2015 1 455 M
Yield 2015 1,87%
PER 2014 44,45
PER 2015 31,26
EV / Sales 2014 4,00x
EV / Sales 2015 3,67x
Capitalization 12 443 M
More Financials
Latest news on UCB SA
07/04 UCB : Acquisition of own shares
06/25 UCB : Patent Issued for Pharmaceutical Composition Comprising Rotigotine Salts (..
06/25 UCB : Acquisition of own shares
06/11 UCB : Patent Issued for Chiral Intermediate, Process for Producing the Same and ..
05/06 UCB : Acquisition of own shares
05/05 UCB : Kremers Urban Pharmaceuticals Assigned Patent
04/29 UCB : ex-dividend day for annual dividend
04/24 UCB : shareholder meeting today
04/24 UCB INTERIM REPORT FOR FIRST THREE M : with a good start into 2014 (UCB Interim ..
04/17UCB SA : quaterly earnings release
03/25 UCB : Convening notice to attend the annual general meeting of shareholders
03/21 UCB : returns global rights to tozadenant to Biotie
More news
Comments 
Advertisement
Income Statement Evolution
UCB SA : Income Statement Evolution
More Financials
EPS Revisions
UCB SA : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF